Law Firm Targets Investors in Multiple Companies
The law firm Faruqi & Faruqi is actively investigating claims and reminding investors of deadlines in securities class actions against multiple companies, including Aquestive Therapeutics, Helen of Troy, and Wealthfront. The flurry of notices suggests a broad push by the firm to recruit plaintiffs for litigation.
Faruqi & Faruqi, a national securities law firm, has a history of recovering hundreds of millions of dollars for investors in securities fraud cases since its founding in 1995. The firm often encourages investors who have suffered significant losses, sometimes specified as exceeding $50,000, to contact them to discuss their legal rights and potentially serve as lead plaintiffs in class action lawsuits. The investigation into Aquestive Therapeutics follows the company's announcement on January 9, 2026, that the FDA found deficiencies in its New Drug Application for Anaphylm. This news precluded discussions on labeling and post-marketing commitments, causing Aquestive's stock to plummet by over 37% on the same day. Helen of Troy is under scrutiny after reporting a nearly 8.9% year-over-year decline in consolidated net sales for the second quarter of fiscal year 2026. The company also disclosed a GAAP diluted loss per share of $13.44, contributing to a stock price drop of approximately 25% on October 9, 2025. Wealthfront's investigation was triggered by its first quarterly report as a public company on January 12, 2026, which revealed a $208 million net deposit outflow, a sharp contrast to the $874 million in inflows during the same period the previous year. Following this news, Wealthfront's stock fell by 16.8%. A significant point in the Wealthfront case is the disclosure that CEO David Fortunato personally owns a 95.1% stake in the company's home-lending subsidiary. This revelation, combined with the poor quarterly results, has led to allegations that the company may have issued materially misleading business information to investors. These "investor alerts" are a common practice in securities law, where firms solicit individuals who have lost money in a particular stock to join a class-action lawsuit. The goal is to pool the claims of many investors into a single case against the company, alleging that it violated federal securities laws. The lead plaintiff in such a case is typically the investor with the largest financial interest in the outcome. This individual directs and oversees the litigation on behalf of the entire class of affected shareholders.
